Startseite Kongressberichte 2017 Symposium Thoracic Oncology – Guidelines and Beyond

Cancer Center Zürich and Thoracic Oncology Center: Symposium Thoracic Oncology – Guidelines and Beyond

Dear colleagues
Since over 5 years the Thoracic Oncology Center is a strong pillar of the Cancer Center Zürich. During this time span our knowledge of the biology of lung cancer has greatly improved. Lung cancer screening is on its way to become a reality and progress has been made in surgical techniques as well as with stereotactic radiotherapy of thoracic malignancies. Also, patients can profit from considerable advances in personalized therapy and immunotherapy leading to new therapeutic concepts. A strong Swiss–Chinese collaboration with the Shanghai Chest Hospital has been established by the Department of Thoracic Surgery over the past eight years and resulted in a fruitful exchange on the science and practice of treatment of chest malignancies.
The Cancer Center Zürich and its Thoracic Oncology Center are proud to invite you for a full day of scientific exchange, and its members are looking forward seeing and discussing with you the current and future developments which are bringing new hope for our patients. 

Prof. Dr. med. Matthias Guckenberger Director Department of Radiation Oncology, Prof. Dr. med. Rolf Stahel Co-Chair Thoracic Oncology Center, Chair Cancer Center Zürich, Prof. Dr. med. Malcolm Kohler Director Department of Pulmonology, Prof. Dr. med. Walter Weder Co-Chair Thoracic Oncology Center, Director Department of Thoracic Surgery

PROGRAM (to see the webcasts click on the session links)
Screening - Chair: Malcolm Kohler
Summarizing the evidence. Carlijn van der Aalst, Erasmus MC, Rotterdam, The Netherlands
Swiss initiative. Milo Puhan, Epidemiology, Biostatistics and Prevention Institute, UZH
Approach the nodule, including case presentations. Daniel Franzen, Thomas Frauenfelder, Didier Schneiter, USZ
Molecular evolution of lung cancer. Ramaswamy Govindan, Washington University School of Medicine, USA
Diagnostic process, including case presentation. Alex Soltermann, USZ
Next generation sequencing and liquid biopsies, including case presentation. Peter Wild, USZ & Alessandra Curioni, USZ
Swiss-Chinese collaboration. Walter Weder, USZ
Overview of lung cancer clinical trials in China. Shun Lu, Shanghai Chest Hospital, China
Da Vinci Robotic System in lung cancer treatment. Qingquan Luo, Shanghai Chest Hospital, China
The application of tissue engineered bronchus in lung cancer treatment: case report. Qiang Tan, Shanghai Chest Hospital, China
Treatment options in localized NSCLC - Chair: Walter Weder
Extending the indication for thoracic surgery, including case presentation. Isabelle Opitz, USZ
Extending the indication for thoracic radiotherapy. Matthias Guckenberger, USZ
Extending the indication for bronchoscopic intervention, including case presentation. Daniel Franzen, USZ
Small cell lung cancer, including case presentation and discussion. Dirk de Ruysscher, Maastro Clinic, The Netherlands
Thymic malignancies, including case presentation and discussion. Nicolas Girard, Hospices Civils de Lyon, France
Mesothelioma, including case presentation and discussion. Isabelle Opitz, USZ
Metastatic disease - Chair: Rolf Stahel
Personalized therapy in metastatic NSCLC, including case presentation. Rolf Stahel, USZ
The advent of immunotherapy for NSCLC. Solange Peters, CHUV Lausanne
Working together makes the difference, a series of illustrative cases from the Cancer Center Zürich. Christian Britschgi, Niklaus Andratschke, USZ
Overcoming resistance to immunotherapy? Rationale for combinatorial treatments. Alessandra Curioni, USZ